Cargando…

Vaccines and Therapies for Biodefence Agents

Detalles Bibliográficos
Autores principales:	Tree, Julia A., Williamson, E. Diane, Rowland, Caroline A., Pitt, Louise M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369933/ https://www.ncbi.nlm.nih.gov/pubmed/25839045 http://dx.doi.org/10.1155/2015/537319

Ejemplares similares

The Impact of “Omic” and Imaging Technologies on Assessing the Host Immune Response to Biodefence Agents
por: Tree, Julia A., et al.
Publicado: (2014)

There are two sides to biodefence
Publicado: (2003)

Applications of microarrays in pathogen detection and biodefence
por: Uttamchandani, Mahesh, et al.
Publicado: (2009)

The evolving field of biodefence: therapeutic developments and diagnostics
por: Burnett, James C., et al.
Publicado: (2005)

A genomics-based approach to biodefence preparedness
por: Fraser, Claire M.
Publicado: (2004)

When it comes to drug discovery not all Gram‐negative bacterial biodefence pathogens are created equal: Burkholderia pseudomallei is different
por: Schweizer, Herbert P.
Publicado: (2012)

HERMES: Delivery of a Speedy Prostate Cancer Treatment
por: Westley, R., et al.
Publicado: (2022)

Novel-agent combination therapies in chronic lymphocytic leukemia: the law of relative contributions
por: Mato, Anthony R., et al.
Publicado: (2022)

The Use and Abuse of Vaccine Therapy
Publicado: (1922)

Use of Essential Oils and Volatile Compounds as Biological Control Agents
por: De Clerck, Caroline, et al.
Publicado: (2021)

Hepatitis B Vaccines and HPV Vaccines Have Been Hailed as Major Public Health Achievements in Preventing Cancer—Could a Schistosomiasis Vaccine be the Third?
por: Hsieh, Michael H., et al.
Publicado: (2015)

RNA Vaccination Therapy: Advances in an Emerging Field
por: Kreiter, Sebastian, et al.
Publicado: (2016)

"Protein Shock" and Intravenous Vaccine Therapy
Publicado: (1919)

Agent
Publicado: (1857)

Anti-amyloid agents for treating incipient Alzheimer’s disease: a new hope?
por: Loureiro, Julia C., et al.
Publicado: (2022)

Advances in cancer therapy: clinical benefit of new cancer drugs
por: Michaeli, Daniel Tobias, et al.
Publicado: (2023)

Dual antiplatelet therapy and newer agents: More efficacy but lets keep the brain safe!!
por: Bhatia, Rohit, et al.
Publicado: (2015)

Identification of Molecular Targets and Anti-Cancer Agents in GBM: New Perspectives for Cancer Therapy
por: D’Amico, Agata Grazia, et al.
Publicado: (2023)

Control of Intracellular Francisella tularensis by Different Cell Types and the Role of Nitric Oxide
por: Newstead, Sarah L., et al.
Publicado: (2014)

COVID-19 vaccines and multiple sclerosis disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2021)

Angiostatic vaccines, an underestimated approach of cancer therapy
por: Griffioen, Arjan W.
Publicado: (2014)

Suicide and the agent–host–environment triad: leveraging surveillance sources to inform prevention
por: Keyes, Katherine M., et al.
Publicado: (2021)

Our Agents
Publicado: (1885)

Immunologic Monitoring of Cellular Immune Responses in Cancer Vaccine Therapy
por: Whiteside, Theresa L., et al.
Publicado: (2011)

Physiologically Based Pharmacokinetics Is Impacting Drug Development and Regulatory Decision Making
por: Rowland, M, et al.
Publicado: (2015)

Welcome to the Journal of Immune Based Therapies and Vaccines (JIBTV)
por: Moss, Ronald B
Publicado: (2003)

Lenvatinib plus pembrolizumab a new effective combination of targeted agents
por: Perez-Fidalgo, J.A., et al.
Publicado: (2023)

Introducing Infectious Agents and Cancer
por: Buonaguro, Franco M, et al.
Publicado: (2006)

Vaccine delivery using nanoparticles
por: Gregory, Anthony E., et al.
Publicado: (2013)

Natural killer cells during acute HIV-1 infection: clues for HIV-1 prevention and therapy
por: Alrubayyi, Aljawharah, et al.
Publicado: (2022)

Molecular therapies and vaccines face the challenges of emerging infectious diseases
por: Patel, Ami, et al.
Publicado: (2022)

Updates and New Perspectives on Adenoviral Gene Therapy and Vaccine Vectors
por: Dobner, Thomas, et al.
Publicado: (2023)

Mechanisms of Extracellular Immunomodulation Mediated by Infectious Agents
por: Viejo-Borbolla, Abel, et al.
Publicado: (2017)

“Contrast agents for optoacoustic imaging: design and biomedical applications”
por: Oraevsky, Alexander A.
Publicado: (2015)

Synthesis and Biological Activity of Antimicrobial Agents
por: Carvalho, M. Fernanda N. N.
Publicado: (2022)

“T”eeing Up A Novel Therapy for Lymphangioleiomyomatosis
por: Wang, Xiaoyun, et al.
Publicado: (2020)

Relapsed/Refractory Chronic Lymphocytic Leukemia: Chemoimmunotherapy, Treatment until Progression with Mechanism-Driven Agents or Finite-Duration Therapy?
por: Cuneo, Antonio, et al.
Publicado: (2019)

Antimicrobial Peptides as Therapeutic Agents
por: Upton, Mathew, et al.
Publicado: (2012)

Natural Compounds as Antimicrobial Agents
por: Franco, Carlos Manuel, et al.
Publicado: (2020)

Antiviral Agents: Discovery to Resistance
por: Adamson, Catherine S.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1e2srsvbo69vmipgp7v2b72p4f